{"id":342366,"date":"2025-08-20T17:48:56","date_gmt":"2025-08-20T17:48:56","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/news-events\/data\/how-to-buy-beam-therapeutics\/"},"modified":"2025-08-20T17:48:56","modified_gmt":"2025-08-20T17:48:56","slug":"how-to-buy-beam-therapeutics","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-beam-therapeutics\/","title":{"rendered":"How to buy Beam Therapeutics Inc. (BEAM) shares &#8211; Investment in Beam Therapeutics Inc. (BEAM) stock"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334054,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-342366","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"How to Buy Beam Therapeutics Inc. (BEAM) Shares - Investment in Beam Therapeutics Inc. (BEAM) Stock","h1_source":{"label":"H1","type":"text","formatted_value":"How to Buy Beam Therapeutics Inc. (BEAM) Shares - Investment in Beam Therapeutics Inc. (BEAM) Stock"},"description":"Learn how to buy Beam Therapeutics Inc. (BEAM) shares with our complete investment guide. Discover current price, risks, and growth potential for this innovative gene editing stock.","description_source":{"label":"Description","type":"textarea","formatted_value":"Learn how to buy Beam Therapeutics Inc. (BEAM) shares with our complete investment guide. Discover current price, risks, and growth potential for this innovative gene editing stock."},"intro":"Thinking about investing in the future of genetic medicine? Beam Therapeutics represents the cutting edge of gene editing technology - a field that could revolutionize healthcare. This isn't just another biotech stock; it's a potential game-changer in precision medicine. We'll break down everything you need to know about investing in BEAM, from current performance to long-term prospects.","intro_source":{"label":"Intro","type":"text","formatted_value":"Thinking about investing in the future of genetic medicine? Beam Therapeutics represents the cutting edge of gene editing technology - a field that could revolutionize healthcare. This isn't just another biotech stock; it's a potential game-changer in precision medicine. We'll break down everything you need to know about investing in BEAM, from current performance to long-term prospects."},"body_html":"<h2>Current Market Position and Entry Point<\/h2> <p>As of August 20, 2025, Beam Therapeutics Inc. (BEAM) is trading at <strong>$16.35<\/strong> per share. This price represents a significant opportunity considering the stock reached its 52-week high of $35.25 just six months ago in February 2025<a href=\"https:\/\/stockscan.io\/stocks\/BEAM\/price-history\">Stockscan<\/a>. <\/p> <p><strong>Critical Date Alert<\/strong>: Mark your calendar for <strong>November 4, 2025<\/strong> - that's when Beam Therapeutics releases its Q3 earnings report<a href=\"https:\/\/public.com\/stocks\/beam\/earnings\">Public.com<\/a>. Historically, biotech earnings can cause dramatic price movements.<\/p> <table> <thead> <tr> <th>Date<\/th> <th>Event<\/th> <th>Pre-News Price<\/th> <th>Post-News Change<\/th> <\/tr> <\/thead> <tbody> <tr> <td>Aug 5, 2025<\/td> <td>Q2 Earnings<\/td> <td>$17.82<\/td> <td>-8.2% (missed revenue)<\/td> <\/tr> <tr> <td>May 2025<\/td> <td>Previous Earnings<\/td> <td>~$26.50<\/td> <td>-20% drop<\/td> <\/tr> <tr> <td>Feb 18, 2025<\/td> <td>Clinical Data<\/td> <td>$29.05<\/td> <td>+21% to $35.25 high<\/td> <\/tr> <tr> <td>Mar 2025<\/td> <td>Negative News<\/td> <td>$35.25<\/td> <td>-15.7% correction<\/td> <\/tr> <tr> <td>Apr 7, 2025<\/td> <td>Market Bottom<\/td> <td>Various<\/td> <td>Hit $13.52 low<\/td> <\/tr> <\/tbody> <\/table> <p>The pattern shows extreme volatility around clinical and financial announcements - typical for development-stage biotechs.<\/p> [cta_green text=\"Start trading\"]<h2>Six-Month Price Journey: Rollercoaster Ride<\/h2> <p>BEAM's performance from March to August 2025 has been nothing short of dramatic:<\/p> <ul> <li><strong>February 2025<\/strong>: Peak excitement - stock hit $35.25 high on positive clinical data<\/li> <li><strong>March 2025<\/strong>: Reality check - corrected 15.68% to $29.05 range<\/li> <li><strong>April 2025<\/strong>: Rock bottom - plunged to 52-week low of $13.52<\/li> <li><strong>May-August 2025<\/strong>: Recovery phase - climbed back to current $16.35 level<\/li> <\/ul> <p>The six-month performance shows a <strong>25.55% decline<\/strong> overall, but the recovery from April lows represents a <strong>21% bounce<\/strong><a href=\"https:\/\/stockscan.io\/stocks\/BEAM\/price-history\">Stockscan<\/a>. This volatility is exactly why biotech investing requires strong nerves and careful timing.<\/p> <h2>Price Forecast: 2025-2030 Outlook<\/h2> <p>Based on current analyst projections and clinical milestones, here's what you might expect:<\/p> <ul> <li><strong>2025 Year-End<\/strong>: $18-22 range (modest recovery as trials progress)<\/li> <li><strong>2026 Target<\/strong>: $24-28 (BEAM-101 BLA submission expected)<a href=\"https:\/\/gov.capital\/stock\/beam-stock\/\">Gov.Capital<\/a><\/li> <li><strong>2028 Projection<\/strong>: $35-45 (potential first commercial approvals)<\/li> <li><strong>2030 Vision<\/strong>: $50-80+ (if platform technology proves successful)<a href=\"https:\/\/stockanalysis.com\/stocks\/beam\/forecast\/\">StockAnalysis<\/a><\/li> <\/ul> <p><strong>Verdict<\/strong>: <strong>BUY for long-term investors<\/strong> - but only with risk capital you can afford to lose.<\/p> <h2>\u26a0\ufe0f Key Risks Every Investor Must Consider<\/h2> <ul> <li><strong>Clinical Trial Failures<\/strong>: 90% of experimental drugs fail - BEAM's entire value depends on successful trials<\/li> <li><strong>Regulatory Hurdles<\/strong>: FDA approvals are unpredictable and can take years<\/li> <li><strong>Cash Burn<\/strong>: $400M annual R&amp;D spend means they need constant funding<a href=\"https:\/\/www.ainvest.com\/news\/beam-therapeutics-narrower-loss-q2-2025-sign-sustainable-turnaround-temporary-bounce-2508\/\">AInvest<\/a><\/li> <li><strong>Competition<\/strong>: CRISPR giants like CRISPR Therapeutics already have approved products<\/li> <li><strong>Dilution Risk<\/strong>: High cash burn may require additional stock offerings<\/li> <\/ul> <h2>\ud83d\udfe2 Positive Signals for 2025 Growth<\/h2> <ul> <li><strong>Clinical Progress<\/strong>: BEAM-302 showed 78% reduction in harmful proteins with mild side effects<\/li> <li><strong>Cash Runway<\/strong>: $1.2B reserves fund operations through 2028<a href=\"https:\/\/www.biospace.com\/employer\/1918902\/beam-therapeutics\">BioSpace<\/a><\/li> <li><strong>Technology Edge<\/strong>: Base editing safer than traditional CRISPR methods<\/li> <li><strong>Market Position<\/strong>: First-mover in next-generation gene editing<\/li> <li><strong>Pipeline Diversity<\/strong>: Multiple programs reduce single-point failure risk<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2> <ol> <li><strong>Start Small<\/strong>: Allocate no more than 2-5% of your portfolio to high-risk biotech<\/li> <li><strong>Dollar-Cost Average<\/strong>: Buy in small increments rather than one lump sum<\/li> <li><strong>Set Stop-Losses<\/strong>: Protect yourself from catastrophic drops<\/li> <li><strong>Monitor Catalysts<\/strong>: Watch for November earnings and clinical updates<\/li> <\/ol> <p>Humorous take: \"Investing in BEAM is like dating a brilliant scientist - incredibly exciting potential, but be prepared for emotional volatility and expensive dates that might not work out!\"<\/p> <h2>\u2705 How to Buy Beam Therapeutics Inc. (BEAM) Shares - Step by Step<\/h2> <table> <thead> <tr> <th>Step<\/th> <th>Action<\/th> <th>Why It Matters<\/th> <\/tr> <\/thead> <tbody> <tr> <td>1<\/td> <td>Choose a Trading Platform<\/td> <td>Ensure it offers NASDAQ access and reasonable fees<\/td> <\/tr> <tr> <td>2<\/td> <td>Complete Account Setup<\/td> <td>Provide identification and funding information<\/td> <\/tr> <tr> <td>3<\/td> <td>Research Current Price<\/td> <td>Check real-time quotes at $16.35 (as of Aug 20)<\/td> <\/tr> <tr> <td>4<\/td> <td>Place Limit Order<\/td> <td>Set maximum price you're willing to pay<\/td> <\/tr> <tr> <td>5<\/td> <td>Monitor Position<\/td> <td>Track performance and set alert thresholds<\/td> <\/tr> <\/tbody> <\/table> <h2>Why Pocket Option Fits New Biotech Investors<\/h2> <p>For those looking to invest in innovative companies like Beam Therapeutics, Pocket Option offers unique advantages:<\/p> <ul> <li><strong>Minimum deposit of $5<\/strong> - perfect for testing biotech investing strategies without major risk<\/li> <li><strong>Quick verification<\/strong> - start trading within minutes with simple document upload<\/li> <li><strong>Flexible trading options<\/strong> - access both traditional investing and quick trading opportunities<\/li> <li><strong>Global accessibility<\/strong> - available in multiple countries with local payment methods<\/li> <\/ul> <h2>Beam Therapeutics in 2025: Gene Editing Pioneer<\/h2> <p>Beam Therapeutics stands at the forefront of genetic medicine revolution. The company specializes in <strong>base editing technology<\/strong> - a more precise and safer alternative to traditional CRISPR gene editing<a href=\"https:\/\/beamtx.com\/science\/\">BeamTx<\/a>. Unlike methods that cut DNA strands, base editing makes single-letter changes without breaking the genetic backbone.<\/p> <p>Their lead programs include:<\/p> <ul> <li><strong>BEAM-101<\/strong>: Sickle cell disease treatment showing promising early results<\/li> <li><strong>BEAM-302<\/strong>: Alpha-1 antitrypsin deficiency therapy with breakthrough data<\/li> <li><strong>CAR-T programs<\/strong>: Next-generation cancer treatments using edited immune cells<\/li> <\/ul> <p>The company maintains a <strong>$1.2 billion cash position<\/strong> that funds operations through 2028, providing runway for clinical development<a href=\"https:\/\/www.biospace.com\/employer\/1918902\/beam-therapeutics\">BioSpace<\/a>.<\/p> <p><strong>Interesting Fact<\/strong>: In 2025, Beam Therapeutics became the first company to demonstrate clinical proof-of-concept that base editing can rewrite a patient's genetic code to correct a disease-causing mutation - a milestone that could redefine genetic medicine.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>Current Market Position and Entry Point<\/h2>\n<p>As of August 20, 2025, Beam Therapeutics Inc. (BEAM) is trading at <strong>$16.35<\/strong> per share. This price represents a significant opportunity considering the stock reached its 52-week high of $35.25 just six months ago in February 2025<a href=\"https:\/\/stockscan.io\/stocks\/BEAM\/price-history\">Stockscan<\/a>. <\/p>\n<p><strong>Critical Date Alert<\/strong>: Mark your calendar for <strong>November 4, 2025<\/strong> &#8211; that&#8217;s when Beam Therapeutics releases its Q3 earnings report<a href=\"https:\/\/public.com\/stocks\/beam\/earnings\">Public.com<\/a>. Historically, biotech earnings can cause dramatic price movements.<\/p>\n<table>\n<thead>\n<tr>\n<th>Date<\/th>\n<th>Event<\/th>\n<th>Pre-News Price<\/th>\n<th>Post-News Change<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Aug 5, 2025<\/td>\n<td>Q2 Earnings<\/td>\n<td>$17.82<\/td>\n<td>-8.2% (missed revenue)<\/td>\n<\/tr>\n<tr>\n<td>May 2025<\/td>\n<td>Previous Earnings<\/td>\n<td>~$26.50<\/td>\n<td>-20% drop<\/td>\n<\/tr>\n<tr>\n<td>Feb 18, 2025<\/td>\n<td>Clinical Data<\/td>\n<td>$29.05<\/td>\n<td>+21% to $35.25 high<\/td>\n<\/tr>\n<tr>\n<td>Mar 2025<\/td>\n<td>Negative News<\/td>\n<td>$35.25<\/td>\n<td>-15.7% correction<\/td>\n<\/tr>\n<tr>\n<td>Apr 7, 2025<\/td>\n<td>Market Bottom<\/td>\n<td>Various<\/td>\n<td>Hit $13.52 low<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The pattern shows extreme volatility around clinical and financial announcements &#8211; typical for development-stage biotechs.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/en\/register\/\" class=\"po-cta-green\">Start trading\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>Six-Month Price Journey: Rollercoaster Ride<\/h2>\n<p>BEAM&#8217;s performance from March to August 2025 has been nothing short of dramatic:<\/p>\n<ul>\n<li><strong>February 2025<\/strong>: Peak excitement &#8211; stock hit $35.25 high on positive clinical data<\/li>\n<li><strong>March 2025<\/strong>: Reality check &#8211; corrected 15.68% to $29.05 range<\/li>\n<li><strong>April 2025<\/strong>: Rock bottom &#8211; plunged to 52-week low of $13.52<\/li>\n<li><strong>May-August 2025<\/strong>: Recovery phase &#8211; climbed back to current $16.35 level<\/li>\n<\/ul>\n<p>The six-month performance shows a <strong>25.55% decline<\/strong> overall, but the recovery from April lows represents a <strong>21% bounce<\/strong><a href=\"https:\/\/stockscan.io\/stocks\/BEAM\/price-history\">Stockscan<\/a>. This volatility is exactly why biotech investing requires strong nerves and careful timing.<\/p>\n<h2>Price Forecast: 2025-2030 Outlook<\/h2>\n<p>Based on current analyst projections and clinical milestones, here&#8217;s what you might expect:<\/p>\n<ul>\n<li><strong>2025 Year-End<\/strong>: $18-22 range (modest recovery as trials progress)<\/li>\n<li><strong>2026 Target<\/strong>: $24-28 (BEAM-101 BLA submission expected)<a href=\"https:\/\/gov.capital\/stock\/beam-stock\/\">Gov.Capital<\/a><\/li>\n<li><strong>2028 Projection<\/strong>: $35-45 (potential first commercial approvals)<\/li>\n<li><strong>2030 Vision<\/strong>: $50-80+ (if platform technology proves successful)<a href=\"https:\/\/stockanalysis.com\/stocks\/beam\/forecast\/\">StockAnalysis<\/a><\/li>\n<\/ul>\n<p><strong>Verdict<\/strong>: <strong>BUY for long-term investors<\/strong> &#8211; but only with risk capital you can afford to lose.<\/p>\n<h2>\u26a0\ufe0f Key Risks Every Investor Must Consider<\/h2>\n<ul>\n<li><strong>Clinical Trial Failures<\/strong>: 90% of experimental drugs fail &#8211; BEAM&#8217;s entire value depends on successful trials<\/li>\n<li><strong>Regulatory Hurdles<\/strong>: FDA approvals are unpredictable and can take years<\/li>\n<li><strong>Cash Burn<\/strong>: $400M annual R&amp;D spend means they need constant funding<a href=\"https:\/\/www.ainvest.com\/news\/beam-therapeutics-narrower-loss-q2-2025-sign-sustainable-turnaround-temporary-bounce-2508\/\">AInvest<\/a><\/li>\n<li><strong>Competition<\/strong>: CRISPR giants like CRISPR Therapeutics already have approved products<\/li>\n<li><strong>Dilution Risk<\/strong>: High cash burn may require additional stock offerings<\/li>\n<\/ul>\n<h2>\ud83d\udfe2 Positive Signals for 2025 Growth<\/h2>\n<ul>\n<li><strong>Clinical Progress<\/strong>: BEAM-302 showed 78% reduction in harmful proteins with mild side effects<\/li>\n<li><strong>Cash Runway<\/strong>: $1.2B reserves fund operations through 2028<a href=\"https:\/\/www.biospace.com\/employer\/1918902\/beam-therapeutics\">BioSpace<\/a><\/li>\n<li><strong>Technology Edge<\/strong>: Base editing safer than traditional CRISPR methods<\/li>\n<li><strong>Market Position<\/strong>: First-mover in next-generation gene editing<\/li>\n<li><strong>Pipeline Diversity<\/strong>: Multiple programs reduce single-point failure risk<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2>\n<ol>\n<li><strong>Start Small<\/strong>: Allocate no more than 2-5% of your portfolio to high-risk biotech<\/li>\n<li><strong>Dollar-Cost Average<\/strong>: Buy in small increments rather than one lump sum<\/li>\n<li><strong>Set Stop-Losses<\/strong>: Protect yourself from catastrophic drops<\/li>\n<li><strong>Monitor Catalysts<\/strong>: Watch for November earnings and clinical updates<\/li>\n<\/ol>\n<p>Humorous take: &#8220;Investing in BEAM is like dating a brilliant scientist &#8211; incredibly exciting potential, but be prepared for emotional volatility and expensive dates that might not work out!&#8221;<\/p>\n<h2>\u2705 How to Buy Beam Therapeutics Inc. (BEAM) Shares &#8211; Step by Step<\/h2>\n<table>\n<thead>\n<tr>\n<th>Step<\/th>\n<th>Action<\/th>\n<th>Why It Matters<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Choose a Trading Platform<\/td>\n<td>Ensure it offers NASDAQ access and reasonable fees<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Complete Account Setup<\/td>\n<td>Provide identification and funding information<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Research Current Price<\/td>\n<td>Check real-time quotes at $16.35 (as of Aug 20)<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Place Limit Order<\/td>\n<td>Set maximum price you&#8217;re willing to pay<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Monitor Position<\/td>\n<td>Track performance and set alert thresholds<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>Why Pocket Option Fits New Biotech Investors<\/h2>\n<p>For those looking to invest in innovative companies like Beam Therapeutics, Pocket Option offers unique advantages:<\/p>\n<ul>\n<li><strong>Minimum deposit of $5<\/strong> &#8211; perfect for testing biotech investing strategies without major risk<\/li>\n<li><strong>Quick verification<\/strong> &#8211; start trading within minutes with simple document upload<\/li>\n<li><strong>Flexible trading options<\/strong> &#8211; access both traditional investing and quick trading opportunities<\/li>\n<li><strong>Global accessibility<\/strong> &#8211; available in multiple countries with local payment methods<\/li>\n<\/ul>\n<h2>Beam Therapeutics in 2025: Gene Editing Pioneer<\/h2>\n<p>Beam Therapeutics stands at the forefront of genetic medicine revolution. The company specializes in <strong>base editing technology<\/strong> &#8211; a more precise and safer alternative to traditional CRISPR gene editing<a href=\"https:\/\/beamtx.com\/science\/\">BeamTx<\/a>. Unlike methods that cut DNA strands, base editing makes single-letter changes without breaking the genetic backbone.<\/p>\n<p>Their lead programs include:<\/p>\n<ul>\n<li><strong>BEAM-101<\/strong>: Sickle cell disease treatment showing promising early results<\/li>\n<li><strong>BEAM-302<\/strong>: Alpha-1 antitrypsin deficiency therapy with breakthrough data<\/li>\n<li><strong>CAR-T programs<\/strong>: Next-generation cancer treatments using edited immune cells<\/li>\n<\/ul>\n<p>The company maintains a <strong>$1.2 billion cash position<\/strong> that funds operations through 2028, providing runway for clinical development<a href=\"https:\/\/www.biospace.com\/employer\/1918902\/beam-therapeutics\">BioSpace<\/a>.<\/p>\n<p><strong>Interesting Fact<\/strong>: In 2025, Beam Therapeutics became the first company to demonstrate clinical proof-of-concept that base editing can rewrite a patient&#8217;s genetic code to correct a disease-causing mutation &#8211; a milestone that could redefine genetic medicine.<\/p>\n"},"faq":[{"question":"Is Beam Therapeutics a good long-term investment?","answer":"For investors with high risk tolerance and long time horizon, yes. The technology is groundbreaking, but clinical success is never guaranteed in biotech."},{"question":"What's the biggest risk with BEAM stock?","answer":"Clinical trial failures. Like most biotechs, their value depends entirely on successful drug development and regulatory approvals."},{"question":"How does base editing differ from CRISPR?","answer":"Base editing makes precise single-letter DNA changes without cutting the DNA strand, potentially offering better safety than traditional CRISPR methods."},{"question":"When might Beam become profitable?","answer":"Realistically not before 2028-2030, as they need to complete trials, gain approvals, and commercialize products."},{"question":"Should I buy before or after earnings?","answer":"For volatile stocks like BEAM, many investors wait until after earnings to avoid surprise announcements, though this means potentially missing big moves."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Is Beam Therapeutics a good long-term investment?","answer":"For investors with high risk tolerance and long time horizon, yes. The technology is groundbreaking, but clinical success is never guaranteed in biotech."},{"question":"What's the biggest risk with BEAM stock?","answer":"Clinical trial failures. Like most biotechs, their value depends entirely on successful drug development and regulatory approvals."},{"question":"How does base editing differ from CRISPR?","answer":"Base editing makes precise single-letter DNA changes without cutting the DNA strand, potentially offering better safety than traditional CRISPR methods."},{"question":"When might Beam become profitable?","answer":"Realistically not before 2028-2030, as they need to complete trials, gain approvals, and commercialize products."},{"question":"Should I buy before or after earnings?","answer":"For volatile stocks like BEAM, many investors wait until after earnings to avoid surprise announcements, though this means potentially missing big moves."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>How to buy Beam Therapeutics Inc. (BEAM) shares - Investment in Beam Therapeutics Inc. (BEAM) stock<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-beam-therapeutics\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How to buy Beam Therapeutics Inc. (BEAM) shares - Investment in Beam Therapeutics Inc. (BEAM) stock\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-beam-therapeutics\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-20T17:48:56+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-beam-therapeutics\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-beam-therapeutics\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"How to buy Beam Therapeutics Inc. (BEAM) shares &#8211; Investment in Beam Therapeutics Inc. (BEAM) stock\",\"datePublished\":\"2025-08-20T17:48:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-beam-therapeutics\/\"},\"wordCount\":17,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-beam-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-beam-therapeutics\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-beam-therapeutics\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-beam-therapeutics\/\",\"name\":\"How to buy Beam Therapeutics Inc. (BEAM) shares - Investment in Beam Therapeutics Inc. (BEAM) stock\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-beam-therapeutics\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-beam-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp\",\"datePublished\":\"2025-08-20T17:48:56+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-beam-therapeutics\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-beam-therapeutics\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-beam-therapeutics\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-beam-therapeutics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How to buy Beam Therapeutics Inc. (BEAM) shares &#8211; Investment in Beam Therapeutics Inc. (BEAM) stock\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"How to buy Beam Therapeutics Inc. (BEAM) shares - Investment in Beam Therapeutics Inc. (BEAM) stock","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-beam-therapeutics\/","og_locale":"en_US","og_type":"article","og_title":"How to buy Beam Therapeutics Inc. (BEAM) shares - Investment in Beam Therapeutics Inc. (BEAM) stock","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-beam-therapeutics\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-20T17:48:56+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-beam-therapeutics\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-beam-therapeutics\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"How to buy Beam Therapeutics Inc. (BEAM) shares &#8211; Investment in Beam Therapeutics Inc. (BEAM) stock","datePublished":"2025-08-20T17:48:56+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-beam-therapeutics\/"},"wordCount":17,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-beam-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-beam-therapeutics\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-beam-therapeutics\/","url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-beam-therapeutics\/","name":"How to buy Beam Therapeutics Inc. (BEAM) shares - Investment in Beam Therapeutics Inc. (BEAM) stock","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-beam-therapeutics\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-beam-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp","datePublished":"2025-08-20T17:48:56+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-beam-therapeutics\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-beam-therapeutics\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-beam-therapeutics\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-beam-therapeutics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/en\/"},{"@type":"ListItem","position":2,"name":"How to buy Beam Therapeutics Inc. (BEAM) shares &#8211; Investment in Beam Therapeutics Inc. (BEAM) stock"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/en\/#website","url":"https:\/\/pocketoption.com\/blog\/en\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":342383,"slug":"how-to-buy-beam-therapeutics","post_title":"Comment acheter des actions Beam Therapeutics Inc. (BEAM) - Investissement dans les actions Beam Therapeutics Inc. (BEAM)","href":"https:\/\/pocketoption.com\/blog\/fr\/news-events\/signal\/how-to-buy-beam-therapeutics\/"},"it_IT":{"locale":"it_IT","id":342384,"slug":"how-to-buy-beam-therapeutics","post_title":"Come acquistare azioni Beam Therapeutics Inc. (BEAM) - Investire in azioni Beam Therapeutics Inc. (BEAM)","href":"https:\/\/pocketoption.com\/blog\/it\/news-events\/signal\/how-to-buy-beam-therapeutics\/"},"pl_PL":{"locale":"pl_PL","id":342385,"slug":"how-to-buy-beam-therapeutics","post_title":"Jak kupi\u0107 akcje Beam Therapeutics Inc. (BEAM) - Inwestycja w akcje Beam Therapeutics Inc. (BEAM)","href":"https:\/\/pocketoption.com\/blog\/pl\/news-events\/signal\/how-to-buy-beam-therapeutics\/"},"es_ES":{"locale":"es_ES","id":342389,"slug":"how-to-buy-beam-therapeutics","post_title":"C\u00f3mo comprar acciones de Beam Therapeutics Inc. (BEAM) - Inversi\u00f3n en acciones de Beam Therapeutics Inc. (BEAM)","href":"https:\/\/pocketoption.com\/blog\/es\/news-events\/signal\/how-to-buy-beam-therapeutics\/"},"th_TH":{"locale":"th_TH","id":342386,"slug":"how-to-buy-beam-therapeutics","post_title":"\u0e27\u0e34\u0e18\u0e35\u0e0b\u0e37\u0e49\u0e2d\u0e2b\u0e38\u0e49\u0e19 Beam Therapeutics Inc. (BEAM) - \u0e01\u0e32\u0e23\u0e25\u0e07\u0e17\u0e38\u0e19\u0e43\u0e19\u0e2b\u0e38\u0e49\u0e19 Beam Therapeutics Inc. (BEAM)","href":"https:\/\/pocketoption.com\/blog\/th\/news-events\/signal\/how-to-buy-beam-therapeutics\/"},"tr_TR":{"locale":"tr_TR","id":342387,"slug":"how-to-buy-beam-therapeutics","post_title":"Beam Therapeutics Inc. (BEAM) Hisseleri Nas\u0131l Al\u0131n\u0131r - Beam Therapeutics Inc. (BEAM) Hisse Senedi Yat\u0131r\u0131m\u0131","href":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-beam-therapeutics\/"},"vt_VT":{"locale":"vt_VT","id":342388,"slug":"how-to-buy-beam-therapeutics","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Beam Therapeutics Inc. (BEAM) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Beam Therapeutics Inc. (BEAM)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-beam-therapeutics\/"},"pt_AA":{"locale":"pt_AA","id":342382,"slug":"how-to-buy-beam-therapeutics","post_title":"Como comprar a\u00e7\u00f5es da Beam Therapeutics Inc. (BEAM) - Investimento em a\u00e7\u00f5es da Beam Therapeutics Inc. (BEAM)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-beam-therapeutics\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/342366","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/comments?post=342366"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/342366\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media\/334054"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media?parent=342366"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/categories?post=342366"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/tags?post=342366"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}